Supporting ECPC’s work in particular taking into account my expertise on cancer survivorship issues including the Right to be Forgotten. From 2020 to the end of 2021, ECPC started a new project on the Right To Be Forgotten with the support and under the supervision of Françoise Meunier. The aim of the initiative was to conduct a legal research project assessing and monitoring the discrimination that cancer survivors face in attempts to obtain a mortgage, loans and life insurances, and other financial services in various EU countries and also to evaluate the EU competency in order to establish a pan European legal framework on the Right to be Forgotten.
This aim has been achieved and published and indeed the Right to be Forgotten has been included among the priorities of both the EU Beating Cancer plan , among the board’s recommendations of the Cancer Mission and more recently within the political Declaration for the trio Presidencies (France , Czech rep and Sweden) signed by the 3 Ministers of Health.
Françoise Meunier served as EORTC Director General from 1991 through to 2015 and oversaw the growth of the EORTC into an international world-class cancer clinical research infrastructure. Upon stepping down as Director General in 2015, Françoise Meunier remained active within EORTC until 2018 as EORTC Director Special Projects where she was a driving force behind activities such as EORTC cancer survivorship initiatives.
She is a member of the Belgian Royal Academy of Medicine since 2006. In 2007, she was conferred the title of Baroness by His Majesty, The King Albert II of Belgium. In 2009, she received the Pezcoller Foundation award as a recognition for her contribution to oncology. She is a Fellow of the European Academy of Cancer Sciences, and Board Member of “Centre Scientifique de Monaco”. She served also as Vice-President of FEAM (Federation of European Academies of Medicine) from May 2015 until May 2021 .
She has been a Board Member of Alliance for Biomedical Research in Europe from 2015 to 2018.
In July 2015, she was admitted to the degree of Doctor of Medical Science (Honoris Causa) by the Queen’s University of Belfast, Northern Ireland, UK. From 2017 until the end of 2020 , she has been member of the Scientific Panel for Health (SPH) of the European Commission.
“Since my graduation as medical Doctor (1974) I worked on cancer clinical research to improve the survival and quality of life of patients facing the diagnosis of cancer , I have also been committed to the management of International cancer clinical research. Tremendous progress have been achieved during these 45 years and as nowadays cancer is no longer a death sentence, I decided to dedicate the last part of my professional live to cancer survivorship issues as cancer patients should not pay twice and getting back to a normal life is crucial for cancer survivors . Changes of approaches and perception are essential from employers, insurance companies, banks and in fact from the whole Society.”
We understand that when you make a donation, you want to know exactly what happens to your money. We aim to be clear and transparent when it comes to using your contributions in our mission to fight cancer.
Your donations not only help us to empower the cancer patient community and make a positive difference to healthcare, treatment and accessibility, but also enable us to:
ensure our members are engaged and feel part of an active community through information, training, unique resources, tools, opportunities and networking at a national and European level
legitimise our position of cancer patient representatives before decision-makers
build a reputation as a cancer patient expert within the scientific community
find partners sharing the same vision, values and goals to work together on projects
get the media’s attention in order to publish and disseminate our messages